To inhibit methylglyoxal detoxification genetically, we utilized CRISPR/Cas9-based genome editing to delete Glo1 from lung cancer cells (Fig. 4a, Supplementary Fig. 4a). This evidence concerns the gene GLO1 and lung cancer.